| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Christian Gluud | Q26265142 |
| Naqash Sethi | Q91104175 | ||
| Janus C Jakobsen | Q41279147 | ||
| P2093 | author name string | Joshua Feinberg | |
| Sanam Safi | |||
| Emil E Nielsen | |||
| P2860 | cites work | A comparison of digoxin and medigoxin in treating atrial fibrillation | Q71362993 |
| Effect of digoxin on the ventricular rate variability during paroxysmal atrial fibrillation | Q71837325 | ||
| Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study | Q72051686 | ||
| A comparison of amiodarone and digoxin for treatment of supraventricular arrhythmias after cardiac surgery | Q72061355 | ||
| Viewpoint: taking into account risks of random errors when analysing multiple outcomes in systematic reviews | Q24185986 | ||
| Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods | Q24288962 | ||
| Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis | Q24289436 | ||
| Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study | Q24653790 | ||
| Digoxin-associated mortality: a systematic review and meta-analysis of the literature | Q27026975 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860606 | ||
| Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials | Q27860735 | ||
| GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | Q27860753 | ||
| Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management | Q28268244 | ||
| Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation | Q72360980 | ||
| Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group | Q73294357 | ||
| A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery | Q74551416 | ||
| International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) adopts Consolidated Guideline on Good Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use | Q74795924 | ||
| Mid- and long-term similarity of ventricular response to paroxysmal atrial fibrillation: digoxin versus placebo | Q77322258 | ||
| The effect of digitalis or a beta-blocker, alone or in combination, on atrial fibrillation at rest and during exercise | Q77567277 | ||
| Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation | Q77822664 | ||
| Overview of endpoints in atrial fibrillation studies | Q81684433 | ||
| Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure | Q83142850 | ||
| Heart rate: surrogate or target in the management of heart failure? | Q84783565 | ||
| 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society | Q86275165 | ||
| Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation | Q39438948 | ||
| Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin | Q39438955 | ||
| Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study | Q39497957 | ||
| Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals | Q39834471 | ||
| Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis | Q40563160 | ||
| Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies | Q41416463 | ||
| A comparison of verapamil and digoxin for heart rate control in atrial fibrillation. | Q42102218 | ||
| Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens | Q42691907 | ||
| Lenient versus strict rate control in patients with atrial fibrillation | Q43494058 | ||
| Comparison of digoxin versus low-dose amiodarone for ventricular rate control in patients with chronic atrial fibrillation | Q43622845 | ||
| VERDICT: the Verapamil versus Digoxin Cardioversion Trial: A randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation | Q43685261 | ||
| Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial | Q43692099 | ||
| Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? | Q43707230 | ||
| Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial | Q43969736 | ||
| Procainamide conversion of acute atrial fibrillation after open-heart surgery compared with digoxin treatment | Q44408554 | ||
| Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study). | Q44542368 | ||
| Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? | Q44684620 | ||
| Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial | Q44703499 | ||
| Impact of atrial fibrillation on the risk of death: the Framingham Heart Study | Q45222306 | ||
| Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate | Q46620374 | ||
| Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials | Q47192223 | ||
| Effects of digoxin on electrocardiogram in patients with acute atrial fibrillation--a randomized, placebo-controlled study. Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group | Q48584696 | ||
| Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo | Q49094883 | ||
| Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study | Q29614197 | ||
| Atrial fibrillation as an independent risk factor for stroke: the Framingham Study | Q29614200 | ||
| 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society | Q29614693 | ||
| Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses | Q29619185 | ||
| Evaluating non-randomised intervention studies | Q29619272 | ||
| Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? | Q29619328 | ||
| GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology | Q29619792 | ||
| Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis | Q30245592 | ||
| Acute ventricular rate control in atrial fibrillation: IV combination of diltiazem and digoxin vs. IV diltiazem alone | Q31920617 | ||
| Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses | Q33372680 | ||
| Estimating required information size by quantifying diversity in random-effects model meta-analyses. | Q33521365 | ||
| Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation | Q33610619 | ||
| Evidence at a glance: error matrix approach for overviewing available evidence | Q33710053 | ||
| Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation | Q34193483 | ||
| Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review | Q34422492 | ||
| Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association | Q34505315 | ||
| Comparison of medigoxin and digoxin in the control of atrial fibrillation | Q34517761 | ||
| Industry sponsorship and research outcome. | Q34551400 | ||
| Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation | Q34984358 | ||
| Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK | Q35582163 | ||
| Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil. | Q35582341 | ||
| Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations | Q36065277 | ||
| Bias in clinical intervention research. | Q36380552 | ||
| Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study | Q36421870 | ||
| Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses | Q37138228 | ||
| Therapeutic considerations in applying rate control therapy for atrial fibrillation | Q37204953 | ||
| Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial | Q37666451 | ||
| Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis | Q37739398 | ||
| SPIRIT 2013 statement: defining standard protocol items for clinical trials | Q38072250 | ||
| Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation | Q38347478 | ||
| Evidence-based clinical practice: Overview of threats to the validity of evidence and how to minimise them | Q38380553 | ||
| Systematic Reviews of Anesthesiologic Interventions Reported as Statistically Significant: Problems with Power, Precision, and Type 1 Error Protection | Q38637092 | ||
| A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial | Q38654100 | ||
| Systematic review and meta-analysis of mortality and digoxin use in atrial fibrillation | Q38804406 | ||
| The Epidemiology of Atrial Fibrillation and Stroke. | Q38826745 | ||
| False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review | Q38926363 | ||
| Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm | Q50750535 | ||
| A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation | Q52076959 | ||
| Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation | Q53228124 | ||
| CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials | Q53475786 | ||
| A comparison of amiodarone and digoxin in the treatment of atrial fibrillation complicating suspected acute myocardial infarction | Q54138497 | ||
| Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial. | Q54260524 | ||
| A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. | Q55036185 | ||
| 2012 focused update of the ESC Guidelines for the management of atrial fibrillation | Q57312493 | ||
| Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem | Q67929049 | ||
| Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation | Q68132194 | ||
| A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation | Q68145281 | ||
| Low- and medium-dose diltiazem in chronic atrial fibrillation: comparison with digoxin and correlation with drug plasma levels | Q68461024 | ||
| Usefulness of labetalol in chronic atrial fibrillation | Q68602054 | ||
| Towards improved control of atrial fibrillation | Q68950317 | ||
| A comparison of verapamil and digoxin in the treatment of atrial fibrillation | Q68950319 | ||
| Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation | Q69994582 | ||
| Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation | Q70240943 | ||
| Digoxin and the geriatric in-patient. A randomized trial of digoxin versus placebo | Q70312141 | ||
| [Comparison between digoxin and atenolol in chronic atrial fibrillation] | Q71330302 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | digoxin | Q422222 |
| polycyclic compound | Q426145 | ||
| atrial fibrillation | Q815819 | ||
| carbohydrate | Q11358 | ||
| atrial flutter | Q1506572 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e0193924 | |
| P577 | publication date | 2018-03-08 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials | |
| P478 | volume | 13 |
| Q89985876 | [Second look: practical diagnostic and therapeutic checks in neurorehabilitation] | cites work | P2860 |
Search more.